CareLit · DOI-Nachweis · Pneumologie
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity
DOI 10.1055/s-0036-1572047
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA D'Urzo, D Singh, E Kerwin, H Lakkis, F Chuecos, G de Miquel, T Grund
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: This was a secondary pooled analysis of ACLIFORM (NCT01462942) and AUGMENT (NCT01437397), two 24-week, randomised, double-blind, Phase III studies of twice-daily (BID) aclidinium/formoterol (AB/FF) fixed-dose combination in patients with COPD and moderate to severe airflow obstruction. Pooled data were stratified by airflow obstruction severity. Methods: Patients received AB/FF 400/12 µg, AB/FF 400/6 µg,…
Zitieren
Zitierempfehlung
A D'Urzo, D Singh, E Kerwin, H Lakkis, F Chuecos, G de Miquel, T Grund (2016) Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity. Pneumologie (02). https://doi.org/10.1055/s-0036-1572047
Mit CareLit weiterarbeiten